IRIDEX Symposium at EURETINA on September 9, 2017

Join us at the EURETINA Congress for a symposium on IRIDEX MicroPulse® Laser in Vascular Macular Disease on Saturday, September 9, 2017 from 10:00 AM - 11:00 AM in room 118 at the Centre de Convencions Internacional in Barcelona, Spain.

Presentations:

1. The science, benefits, and utility of MicroPulse® Technology
   by Marco Zarbin, MD, PhD, FACS
   Rutgers-New Jersey Medical School, Newark, NJ, USA
2. MicroPulse® Laser Therapy in DME: morphologic and functional safety and efficacy
   by Stela Vujosevic, MD, PhD, FEBO (Moderator & Presenter)
   University Hospital Maggiore della Caritá, Novara, Italy
3. TxCell™-Guided MicroPulse: safe, effective and immediate care for CSR patients
   by Munir Escaf, MD
   Centro Oftalmologico Carriazo, Barranquilla, Colombia

Webinar: IRIDEX MicroPulse® Laser Therapy for Macular Edema in Multiple Etiology: An Essential Asset for a Comprehensive Practice

If you missed our latest webinar, you can now watch it at any time. In this 1-hour webinar, MicroPulse experts, Dr. Ahad Mahootchi (The Eye Clinic of Florida), Dr. Brandon Phillips (Carolina Vision Center), and Dr. Jason Friedrichs (Friedrichs Eye) talked about the benefits of incorporating IRIDEX MicroPulse® Laser Technology into your practice. They discussed over 10 cases and told participants how to reduce injection treatment burden, increase practice efficiencies, and how to select and treat patients.

Physician Testimonial

"Compared to other lasers, the IQ 532™ Laser with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears. I'm comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage." - Dr. David Gossage

Question of the Month

Can non-IRIDEX lasers use MicroPulse® Technology?

No. Non-IRIDEX lasers cannot use MicroPulse® Technology because MicroPulse is patented and exclusively used by IRIDEX. Other manufacturers have tried to mimic MicroPulse, but their technologies have not been tested for safety and efficacy for 20 years, like MicroPulse has.

About IRIDEX & MicroPulse® Therapy

IRIDEX is a worldwide provider of laser-based medical systems, delivery devices, and consumable instrumentation for the treatment of glaucoma and retinal diseases. Our products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of 70 independent distributors into over 100 countries. MicroPulse® Laser Technology is a tissue-sparing solution for the treatment of retinal diseases and glaucoma. With MicroPulse therapy, a continuous-wave laser beam is chopped into a train of tiny, repetitive, low energy pulses separated by a brief rest period, which allows the tissue to cool between laser pulses.

The Pulse  •  Events  •  News  •  Contact Us

© 2017 IRIDEX. All rights reserved.
IRIDEX, the IRIDEX LOGO, IQ 577, IQ 532, MicroPulse, and the MicroPulse logo are registered trademarks or trademarks of IRIDEX.